Proven and reliable efficacy: 4 Billion Pigs Protected against M. hyo, PCV 2 and PRRS with vaccines from Boehringer Ingelheim Animal Health

Having reached the milestone of 1 billion doses sold since launch, yet another vaccine of Boehringer Ingelheim Animal Health crosses a significant threshold making it one of the leading vaccines for the control of Mycoplasma hyopneumoniae globally¹.
Mycoplasma hyopneumoniae is recognized as a leading cause of respiratory disease in swine. M. hyo infection results in lung lesions, increased susceptibility to other respiratory pathogens and ultimately has a significant impact on pig health.

This milestone comes only months after two other historical events for Boehringer Ingelheim’s swine vaccine portfolio: In September 1 billion doses of Ingelvac PRRS^® MLV had been sold and in October 2 billion pigs had been protected from Porcine Circovirus Disease with Ingelvac CircoFLEX^®. Altogether Boehringer Ingelheim Animal Health has now been able to protect 4 billion pigs against PRRS, PCV 2 and M. hyo.

George Heidgerken, Head of Boehringer Ingelheim Animal Health, states: “We are proud of our swine vaccine portfolio and the achievement of multiple milestones over the last months, including reaching 1 billion doses of Ingelvac MycoFLEX^® now. M. hyo infection has a negative effect on animal wellbeing and can cause major economic losses in pig production. Controlling infections, which includes management interventions and vaccination with Ingelvac MycoFLEX^® provides optimum results.”

The swine vaccine Ingelvac MycoFLEX^® is registered in 58 countries and based on the ImpranFLEX^® Adjuvant Platform, which allows for fresh, on-farm mixing with Ingelvac CircoFLEX^® to form FLEXcombo^®. FLEXcombo^®provides proven protection against Porcine Circo virus and M. hyo without compromising efficacy and safety with just one single shot around weaning.

Ingelvac MycoFLEX^® is also the trusted mixing partner for 3FLEX^®, the only approved combination vaccine to protect against 3 of the most devastating swine diseases; PCV2, M. hyo and PRRS, with a single injection².

1) Based on Year to Date September 2016, Data on file
2) 3FLEX^® is approved in USA, Canada, Mexico, Philippines, Thailand, Japan and Korea

December 13, 2016 - Boehringer